Maturitas
Volume 56, Issue 2 , Pages 113-121 , 20 February 2007

Clinical aspects of obesity in the gynecological endocrinologicaly practice

  • Andrzej Milewicz

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Endocrinology, Diabetology and Isotope Treatment, Medical University Wroclaw, 50-367, Pasteura Str. 4, Poland. Tel.: +48 71 7842545.
    • ,
  • Diana Jedrzejuk

Received 2 November 2005 ,Revised 17 July 2006 ,Accepted 17 July 2006.

References 

  1. Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab. 2004;89(6):2522–2525
  2. Milewicz A, Jedrzejuk D, Lwow F, et al. Prevalence obesity in Poland. Obes Rev. 2005;6(2):113–114
  3. Dubnov G, Brzezinski A, Berry EM. Weight control and the management of obesity after menopause: the role of physical activity. Maturitas. 2003;44:89–101
  4. Milewicz A, Lwow F, Lintowska A, et al. Health behaviours of chosen Lower Silesia, population and obesity problems. Adv Clin Exp Med. 2003;12(3 (Suppl. 1)):43–51
  5. Zdrojewski T. Selected problem of the frequency and hipertension treatment in Poland on the basis of NATPOL PLUS. Medycyna Praktyczna. 2003;2:10–15
  6. Panagiotakos DB, Polychronopolus E. The role of Mediterranean diet in the epidemiology of metabolic syndrome: converting epidemiology to clinic practice. Lipids Health Dis. 2005;4:7–20
  7. Grundy SM. Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–2600
  8. Clinical Guidelines on the identification, evaluation and treatment of overweight and obesity adults—the evidence raport. National Institutes of Health. Obes Res 1998; 6(Suppl 2):51S–209S.
  9. The IDF consensus world-wide definition of the metabolic syndrome. Berlin 14th April 2005 http://www.idf.org/.
  10. Tremblay A, Bouchard L, Bouchard C, et al. Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young female. J Clin Endocrinol Metab. 2003;88(7):3141–3145
  11. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583–2589
  12. Milewicz A. Obesity fenotypes, body mass composition and metabolic profile. Endocrinol Obes Metab Disord. 2005;1:15–20
  13. Karelis AD, St-Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know ?. J Clin Endocrinol Metab. 2004;89(6):2569–2575
  14. Muscelli E, Camastra S, Gstaldelli A, et al. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients. Int J Obes Relat Metab Disord. 1998;22:262–267
  15. Sims EA. Are there persons who are obese, but metabolically healthy?. Metabolism. 2001;50(12):1499–1504
  16. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab. 2004;1:12–36
  17. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697–738
  18. Osttosson M, Lonnroth P, Bjorntrop P, et al. Effects of cortisol and growth hormone on lipolisis in human adipocyte tissue. J Clin Endocrinol Metab. 2000;85(2):799–803
  19. Miller KK, Biller BM, Lipman JG, et al. Truncal adiposity, relative growth hormone deficiency and cardiovascular risk. J Clin Endocrinol Metab. 2005;90(2):768–774
  20. Hrebicek J, Janout V, Malinickowa J, et al. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assesment and prevention. J Clin Endocrinol Metab. 2002;87:144–147
  21. Bonora E, Tragher G, Aleberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the essessment of insulin sensitivity. Diab Care. 2000;23:57–62
  22. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004;19(1):41–47
  23. Guzick DS. Editorial: cardiovascular risk in PCOS. J Clin Endocrin Metab. 2004;89(8):3695–3996
  24. Orio F, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational analytical, prospective case-control study. J Clin Endocrinol Metab. 2004;89(8):3696–3701
  25. Bohdanowicz-Pawlak A, Jakubowska J, Szymczak J, Bednarek-Tupikowska , Milewicz A. The effect of metformin on plasma adiponectin and resistin levels in PCOS women. In: Medimond International Proceedings of the 12th International Congress of Endocrinology. 2004;p. 25–28
  26. Azzis R. Polycistic ovary syndrome, insulin resistance and molecular defects of insulin signaling. J Clin Endocrinol Metab. 2002;87(9):4085–4093
  27. Festa A, D’Agostino RJ, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42–47
  28. Kelly CS, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455
  29. Cibula D, Cifkowa R, Fanta M, et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod. 2000;14:785–789
  30. Elting MW, Koresen TJM, Bezemer PD, et al. Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of Dutch PCOS population. Hum Reprod. 2001;16:556–560
  31. Margolin E, Zhornitzki T, Kopernik G, et al. Polycystic ovary syndrome in postmenopausal women-marker on the metabolic syndrome. Maturitas. 2005;5:331–336
  32. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of third report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–2497.
  33. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat and inflammation. J Clin Endocrinol Metab. 2004;89(11):5517–5522
  34. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome prevalence and associated risk factor findings in the US population from the Third National Heath and Nutrition Examination Survey 1988–1994. Arch Intern Med. 2003;163:427–436
  35. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–2411
  36. Tchernof A, Desmeules A, Richard CH, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 2004;89(7):3425–3430
  37. Milewicz A, Tworowska U, Demmisie M. Menopausal obesity-myth or fact?. Climacteric. 2001;4:273–283
  38. Kershaw E, Fieler J. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–2556
  39. Garaulet M, Viguerie N, Porubsky S, et al. Adiponectin gene experession and plasma values in obese women during very low calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab. 2004;89:756–760
  40. Shuldinwer AR, Hopman N, Pollin T. Editorial: hepatic lipase genotype, diabetes risk and implications for preventive medicine. J Clin Endocrinol Metab. 2004;89(5):2015–2018Nestler JH. Viewpoints on PCOS. Clinical researcher. Endocr News. 2004;29(4):15–17
  41. Simpson E, Rubin G, Clyne C, et al. The role of local estrogen biosynthesis in male and females. Trends Endocrinol Metab. 2000;11(5):184–188
  42. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristic associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?. J Clin Endocrinol Metab. 2001;88(3):1020–1025
  43. Pertyński T, Cypryk K, Nadel I, et al. Studies on the incidence and clinical significance of the polymetabolic syndrome in menopause. In:  Genazzani AR,  Artini PG editor. New technologies for gynecologic and obstetrics investigation. Rome: CIC Edizioni Internationali; 1999;p. 275–279
  44. Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausel transition: the study of Women's Health across the Nation (SWAN) daily hormone study. J Clin Endocrinol Metab. 2004;89(6):2622–2631
  45. Randolph J, Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size and menopoausal status. J Clin Endocrinol Metab. 2003;88(4):1516–1522
  46. Parsey KS, Pong A. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception. 2000;61:105–111
  47. Milewicz A, Jedrzejuk D, Arkowska A. Plasma resistin levels in obese women in polycystic ovary syndrome before and after sibutramine treatment. Int J Gynecol Obstet. 2003;83(Suppl 3):THP10: 79
  48. Boguszewski C, Milewicz A. Drug management of obesity. In: Medimond International Proceedings of the 12th International Congress of Endocrinology. 2004;p. 1–6
  49. Torgerson J, Hauptman J, Boldrin M, et al. Xenical in the prevention of diabetes in obese subjects (XENDOS) study. Diab Care. 2004;27(1):155–161
  50. Fleming R, Hopkinson Z, Wallance M, et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo controlled trial. J Clin Endocrinol Metab. 2002;87(2):569–574
  51. Jakubowicz D, Iuorno M, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524–529
  52. Caballero A, Delgado A, Aguilar-Salinas C, et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled randomized clinical trial. J Clin Endocrinol Metab. 2004;89(8):3943–3948
  53. Futterweit W. Viewpoints on PCOS: clinical practitioner. Endocr News. 2004;29(4):18–19
  54. Dos Reis CM, de Melo NR, Meirelles ES, et al. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas. 2003;(46):59–68
  55. Khoo CL, Perera M. Diabetes and the menopause. J Brit Menopause Soc. 2005;11(1):1–6
  56. Skouby SO, Al-Azzawi F, Barlow D, et al. Climacteric medicine: European menopause and andropause society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas. 2005;51:8–14
  57. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendokrinology. 2003;28:39–53
  58. Green JS, Stanforth PR, Rankinen I, et al. The effects of exercise training on abdominal visceral fat, body composition and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study. Metabolism. 2004;53(9):1192–1196
  59. Mogul HR, Petersen SJ, Weinstein BI, et al. Long-term (2–4 year) weight reduction with metformin plus carbohydrate modified diet in euglycemic, hyperinsulinemic women (Syndrome W). Heart Dis. 2003;5(6):384–392
  60. Prisant LM. Preventing type 2 diabetes mellitus. J Clin Pharmacol. 2004;44(4):406–413
  61. Milewicz A, Szymanski W, Ruzylo W, et al. Polish concensus: procedure in case of estrogen deficiency in women after breast cancer therapy. Gynecol Endocrinol. 2002;16(5):385–389
  62. Rosen CJ, Hochberg MC, Bonnick SL, et al. Fosamax Actonel Comparison Trial Investigators. Treatment with once-weekly alendronate 70mg compared with once-weekly risedronate 35mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res. 2005;20(1):141–151
  63. Serdelowa-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17-beta. Eur J Endocrinol. 2003;149:351–362
  64. Secreto G, Chiechi LM, Amadori A, et al. Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas. 2004;47:11–20

PII: S0378-5122(06)00273-8

doi: 10.1016/j.maturitas.2006.07.005

Maturitas
Volume 56, Issue 2 , Pages 113-121 , 20 February 2007

Article Tools